A Novel Quantitative Method for Analyzing Desmopressin in Human Plasma Using Liquid Chromatography-Tandem Mass Spectrometry.

Therapeutic Drug Monitoring
Nico C B de JagerRon A A Mathôt

Abstract

Desmopressin (D-amino D-arginine vasopressin: dDAVP) is used for the treatment of patients with hemophilia A and Von Willebrand disease. Studies on the rationale of dosing are scarce and mainly focus on the underlying causes of the vast differences in desmopressin response among individuals. The aim of this study was to develop and validate a liquid chromatography-tandem mass spectrometry (LC-MS/MS) method for the quantification of desmopressin in human plasma for identifying its pharmacokinetics and its therapeutic effect relationship in patients with bleeding disorder. The method entails solid-phase extraction with ion exchange for sample clean-up, followed by an LC-MS/MS run. The technique has been validated for analytical selectivity as well as specificity, process efficiency, linearity, accuracy, imprecision, and stability. This method showed good selectivity because no significant chromatographic matrix interferences were observed. The determination coefficient (R) of the calibration curves was ≥0.990. Analyte accuracy ranged from 89.2% to 111.8%, and the between- and within-run imprecision was less than 9.3% in a plasma concentration and range from 60 to 3200 pg/mL. Samples were stable during 3 freeze/thaw cycles with an...Continue Reading

References

Jun 15, 2004·Journal of Pharmaceutical and Biomedical Analysis·Melkamu Getie, Reinhard H H Neubert
Jul 26, 2006·Analytical and Bioanalytical Chemistry·Maria Careri, Alessandro Mangia
Oct 23, 2009·Journal of Pharmacokinetics and Pharmacodynamics·Martin J Wolfsegger, Thomas Jaki
Feb 10, 2012·Analytical and Bioanalytical Chemistry·Simone EspositoPeter Van Eenoo
Jun 4, 2015·Haemophilia : the Official Journal of the World Federation of Hemophilia·S C M StoofM J H A Kruip
Feb 27, 2016·Blood·Jonathan C RobertsUNKNOWN Zimmerman Program Investigators
Jun 27, 2017·Journal of Internal Medicine·L BankirN G Morgenthaler
Feb 7, 2018·Journal of Pharmaceutical Analysis·Shiva Kumar GudlawarJaya Dwivedi
Mar 25, 2018·Haemophilia : the Official Journal of the World Federation of Hemophilia·H C A M HazendonkUNKNOWN “OPTI-CLOT” and “WIN” study group

❮ Previous
Next ❯

Citations

Dec 15, 2020·Haemophilia : the Official Journal of the World Federation of Hemophilia·Lisette M SchütteMarieke J H A Kruip

❮ Previous
Next ❯

Related Concepts

Related Feeds

Blood Clotting Disorders

Thrombophilia includes conditions with increased tendency for excessive blood clotting. Blood clotting occurs when the body has insufficient amounts of specialized proteins that make blood clot and stop bleeding. Here is the latest research on blood clotting disorders.

Related Papers

Anaesthesia
B P Bidstrup, D Royston
Haemophilia : the Official Journal of the World Federation of Hemophilia
M C McCormickJ D Cooper
Annals of Internal Medicine
S M Picca
Journal of the American Academy of Child and Adolescent Psychiatry
A von Gontard, G Lehmkuhl
© 2021 Meta ULC. All rights reserved